IRVINE, Calif., June 8, 2021 /PRNewswire/ -- Allergan Aesthetics,
an AbbVie company (NYSE: ABBV), is changing the way
BOTOX® Cosmetic, the #1 selling neurotoxin
treatment1, is connecting with consumers. Today, the
brand is launching 'See Yourself', a new campaign featuring
documentary style shorts that dive deep into the stories of real
BOTOX® Cosmetic patients - people of all shapes, sizes,
backgrounds, colors, and origins. BOTOX® Cosmetic is the
first brand in the category to focus on the unique journeys of its
consumers, aiming to create greater transparency and a
judgement-free dialogue around the decision to choose an aesthetic
treatment for yourself.
Experience the interactive Multimedia News Release here:
https://www.multivu.com/players/English/8909451-allergan-aesthetics-botox-cosmetic-onabotulinumtoxina-new-campaign/
"BOTOX® Cosmetic is honoring and celebrating the
dynamic people who use our products. We know that getting treated
with BOTOX® Cosmetic is something people do for
themselves. Whether it is a milestone moment or a part of your
regular routine, both are driven by the desire for the image in the
mirror to reflect how you see yourself. Each person's story and
journey are different," says Carrie
Strom, Senior Vice President, AbbVie and President, Global
Allergan Aesthetics. "This campaign is just the beginning, our goal
is that through authentic storytelling, people will connect with
the brand and we can continue to foster a supportive, open, and
inclusive space that is free from judgement about aesthetic
treatment decisions."
As people begin to embrace meeting up in-person again, society
is feeling like they have a lot to celebrate; after experiencing
mostly virtual social interactions, consumer interest in aesthetic
treatments has been on the rise. Loyal patients excited to get back
to their provider or anyone who is curious about BOTOX®
Cosmetic, are invited to follow along with these real patient
stories by viewing a series of documentary shorts which will be
released across digital, social, and broadcast platforms throughout
2021. The shorts were directed by renowned documentarian and famed
storyteller Errol Morris, who was
inspired by the complexity of self-image. Using a mirror and a
simple question, "how do you see yourself?", Morris unlocks a wide
range of emotions from people. The documentary style shorts
introduce viewers to individuals like Stephen, a makeup artist who
after a life-changing event felt it was time to do something for
himself. Other stories include those of Chi-Lan and Monique, who
after spending time caring for others decided it is now time to
focus on themselves. These stories are authentic, honest, and
relatable and reflect that a BOTOX® Cosmetic patient is
likely someone you know.
"These shorts are true to what I see daily in my practice. Yes,
people come to me seeking treatment with BOTOX®
Cosmetic, but there is so much more behind why they are in my
office," says Dr. Michelle Henry, Board Certified
Dermatologist. " I have the opportunity to meet some of the most
amazing people and I get to hear their stories while they're
sitting in the treatment room. Each story is unique. Many stories
are touching while others make me smile; however, the commonality
between them all is the fact that seeking out treatment with
BOTOX® Cosmetic is something people choose to for
themselves. I see myself, my patients, my friends and my family in
this campaign."
Repeated muscle contractions from frowning, squinting, or
raising eyebrows cause skin to furrow and fold, gradually resulting
in the formation of facial lines.
BOTOX® Cosmetic is the first and only product of
its kind FDA-approved to treat three areas, temporarily improving
the appearance of moderate to severe forehead lines, glabellar
lines and crow's feet in adults.2 In fact, research has
shown that patients reported a high (88%) satisfaction rate when
they were treated in all three areas, as part of the forehead line
clinical trials.3 Physicians have relied on
BOTOX® Cosmetic for more than 19 years4, and
in a survey from 2018, approximately 8 out of 10 providers (n=484)
reported they choose BOTOX® Cosmetic when injecting a
neurotoxin for themselves or a family member.5
Watch 'See Yourself' shorts at
www.BOTOXCosmetic.com and @BotoxCosmetic on social. New
stories and content will be unveiled throughout the year. Anyone
who wants to continue the movement to create a judgement-free
dialogue around aesthetics can share their real stories with
#SeeYourself. To learn more about treatment with BOTOX®
Cosmetic or to find a provider please visit
www.BOTOXCosmetic.com.
Consumers who receive aesthetic treatment with BOTOX®
Cosmetic can also enroll in Allē, Allergan Aesthetics loyalty
rewards program, to unlock access to curated content, exclusive
offers, and personalized rewards that can be used for savings on
the Allergan Aesthetics portfolio of products when redeemed at a
participating provider's office (subject to program terms and
conditions). Allē is the first and only loyalty program in the
aesthetics market to also offer consumers the ability to earn
points on over 40 non-Allergan Aesthetics treatments and
brands.
BOTOX® Cosmetic Important Information
BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you
have any of these problems any time (hours to weeks) after
injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening
of associated muscles, can be severe and result in loss of life.
You are at the highest risk if these problems are pre-existing
before injection. Swallowing problems may last for several
months.
- Spread of toxin effects. The effect of botulinum toxin may
affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if
you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients);
had an allergic reaction to any other botulinum toxin product such
as Myobloc® (rimabotulinumtoxinB), Dysport®
(abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA);
have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions,
including: plans to have surgery; had surgery on your face;
have trouble raising your eyebrows; drooping eyelids; any other
abnormal facial change; are pregnant or plan to become pregnant (it
is not known if BOTOX® Cosmetic can harm your unborn
baby); are breast-feeding or plan to (it is not known if
BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, and herbal
supplements. Using BOTOX® Cosmetic with certain
other medicines may cause serious side effects. Do not start any
new medicines until you have told your doctor that you have
received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic
include: dry mouth; discomfort or pain at the injection
site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and
eyebrows, swelling of your eyelids and dry eyes.
APPROVED USES
BOTOX® Cosmetic is a prescription medicine that is
injected into muscles and used to temporarily improve the look of
moderate to severe forehead lines, crow's feet lines, and frown
lines between the eyebrows in adults.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product
Information including Boxed Warning and Medication
Guide.
About Allergan Aesthetics
Allergan Aesthetics,
an AbbVie company, develops, manufactures, and markets a portfolio
of leading aesthetics brands and products. Their aesthetics
portfolio includes facial injectables, body contouring, plastics,
skin care, and more. Their goal is to consistently provide
customers worldwide with innovation, education, exceptional
service, and a commitment to excellence, all with a personal
touch.
About AbbVie
AbbVie's mission is to discover
and deliver innovative medicines that solve serious health issues
today and address the medical challenges of tomorrow. We strive to
have a remarkable impact on people's lives across several key
therapeutic areas: immunology, oncology, neuroscience, eye care,
virology, women's health and gastroenterology, in addition to
products and services across its Allergan Aesthetics portfolio. For
more information about AbbVie, please visit us
at www.abbvie.com. Follow @abbvie on Twitter, Facebook,
Instagram, YouTube and LinkedIn.
References
- Data on File, Allergan; Aesthetic Monthly Tracker Report,
March 2021.
- BOTOX® Cosmetic Prescribing Information, July 2020.
- Data on File, Allergan, 2016; Clinical Study Report
Satisfaction Table
- Department of Health and Human Services FDA Approval Letter for
BOTOX® Cosmetic for Glabellar Lines, 2002.
- Data on File, Allergan; Neurotoxin Monthly Tracker Report,
July 2017.
View original
content:http://www.prnewswire.com/news-releases/allergan-aesthetics-and-botox-cosmetic-onabotulinumtoxina-put-real-stories-at-the-forefront-in-new-campaign-301307465.html
SOURCE AbbVie